Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist
Open Access
- 1 December 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 113 (4), 1333-1343
- https://doi.org/10.1111/j.1476-5381.1994.tb17144.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Antithrombotic Effects of DMP 728, a Platelet GPIIb/IIIa Receptor Antagonist, in a Canine Model of Arterial ThrombosisJournal of Cardiovascular Pharmacology, 1994
- A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Importance of platelets in myocardial injury after reperfusion in the presence of residual coronary stenosis in dogsAmerican Heart Journal, 1993
- Antiplatelet Agents in the Prevention and Therapy of ThrombosisAnnual Review of Medicine, 1992
- The Physiologic Replacement of InsulinNew England Journal of Medicine, 1990
- RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.JCI Insight, 1989
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- The Platelet Membrane Glycoprotein IIb/IIIa ComplexAnnals of the New York Academy of Sciences, 1987
- Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplastyThe American Journal of Cardiology, 1987
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985